Back
Trevi Therapeutics Stock Price Chart

AI Marketing Shift Is Happening–Act Before It's Too Late!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Buy
71
TRVI
Trevi Therapeutics
Last Price:
$5.81
Seasonality Move:
25.18%
7 Day Trial
ALL ACCESS PASS
$
7

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
-
The current trend is moderately bullish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.48 | Sell |
20-day SMA: | 5.95 | Buy |
50-day SMA: | 4.85 | Buy |
200-day SMA: | 3.54 | Buy |
8-day EMA: | 6.42 | Sell |
20-day EMA: | 6.01 | Buy |
50-day EMA: | 5.17 | Buy |
200-day EMA: | 3.81 | Buy |
Trevi Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.52 | Buy |
Relative Strength Index (14 RSI): | 60.68 | Buy |
Chaikin Money Flow: | -128137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.65 - 6.69) | Buy |
Bollinger Bands (100): | (2.95 - 5.29) | Buy |
Trevi Therapeutics Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.29 while TRVI 8-day simple moving average is 6.48, which is a Sell signal.
-
The stock price of TRVI is 6.29 while Trevi Therapeutics 20-day SMA is 5.95, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 4.85 while TRVI share price is 6.29, making it a Buy technically.
-
TRVI stock price is 6.29 and Trevi Therapeutics 200-day simple moving average is 3.54, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
71
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $6.29. The Score for TRVI is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
608.1M
Price in USD:
6.29
Share Volume:
2.6M
Trevi Therapeutics 52-Week Range
52-Week High:
7.39
52-Week Low:
2.30
Buy
71
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 6.29 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.29 while TRVI 8-day exponential moving average is 6.42, which is a Sell signal.
-
The stock price of TRVI is 6.29 while Trevi Therapeutics 20-day EMA is 6.01, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 5.17 while TRVI share price is 6.29, making it a Buy technically.
-
TRVI stock price is 6.29 and Trevi Therapeutics 200-day simple moving average is 3.81, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.52, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 60.68, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (4.65 - 6.69), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (2.95 - 5.29), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.